medmix Past Earnings Performance
Past criteria checks 0/6
medmix's earnings have been declining at an average annual rate of -40.2%, while the Medical Equipment industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 3.6% per year.
Key information
-40.2%
Earnings growth rate
-52.0%
EPS growth rate
| Medical Equipment Industry Growth | 11.1% |
| Revenue growth rate | 3.6% |
| Return on equity | -0.2% |
| Net Margin | -0.4% |
| Next Earnings Update | 26 Feb 2025 |
Recent past performance updates
Recent updates
medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Aug 11
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return
Dec 19An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued
Oct 27Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital
Aug 16There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings
Feb 28medmix (VTX:MEDX) May Have Issues Allocating Its Capital
Jan 14Revenue & Expenses Breakdown
How medmix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 480 | -2 | 116 | 27 |
| 31 Mar 24 | 483 | -1 | 117 | 26 |
| 31 Dec 23 | 487 | 0 | 119 | 26 |
| 30 Sep 23 | 481 | 5 | 113 | 25 |
| 30 Jun 23 | 475 | 10 | 108 | 24 |
| 31 Mar 23 | 476 | 11 | 105 | 24 |
| 31 Dec 22 | 477 | 12 | 103 | 24 |
| 30 Sep 22 | 478 | 21 | 102 | 23 |
| 30 Jun 22 | 480 | 31 | 101 | 23 |
| 31 Mar 22 | 468 | 37 | 98 | 23 |
| 31 Dec 21 | 457 | 44 | 96 | 23 |
| 30 Sep 21 | 435 | 36 | 92 | 23 |
| 30 Jun 21 | 414 | 28 | 89 | 23 |
| 31 Mar 21 | 382 | 19 | 85 | 22 |
| 31 Dec 20 | 351 | 10 | 81 | 20 |
| 31 Dec 19 | 421 | 25 | 86 | 23 |
| 31 Dec 18 | 454 | 52 | 85 | 23 |
Quality Earnings: MEDX is currently unprofitable.
Growing Profit Margin: MEDX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MEDX is unprofitable, and losses have increased over the past 5 years at a rate of 40.2% per year.
Accelerating Growth: Unable to compare MEDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MEDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: MEDX has a negative Return on Equity (-0.21%), as it is currently unprofitable.